Literature DB >> 35774844

Colonic schwannoma: A case of unusual presentation and outcome.

Salsabil Nasri1, Mohamed Hedi Mraidha1, Mehdi Ben Abdelkrim1, Sabri Youssef1, Fehmi Hamila1, Mohamed Amine Elghali1.   

Abstract

BACKGROUND: Schwannomas are mesenchymal tumors arising from neural sheath cells and whose diagnosis is based on immunohistochemistery. The digestive and especially colonic location of this tumor is rare. Commonly described in elderly patient, their malignancy is unusual. CASE REPORT: We report the case of a 23-year-old girl, with learning disability, operated in emergency for acute peritonitis. Peroperatively, we discovered a peritonitis secondary to a bulky perforated cecal tumor. We performed a right colectomy and an ileostomy. The posterior margin of the resection was macroscopically involved. The diagnosis of colonic schwannoma was confirmed with immunopathological examination of the surgical specimen. Surgical exploration 4 months later and morphological investigations during 2 years showed stability of the tumoral residue in the right iliac fossa. However, we noticed, on CT scanning control 2 years postoperatively, the appearance of a mesenteric recurrence. Exploratory laparotomy confirmed the unresectability of this mesenteric mass and showed the presence of multiple parietal nodules whose biopsies revealed their neurofibromatous nature. The 4 year follow-up of the patient didn't reveal any complication rather than need to right nephrostomy due to ureter compression by the primary tumoral residue. DISCUSSION: Colonic schwannoma is a rare disease, commonly described in uncomplicated stages. The learning disability of our patient had favorized the absence of declared symptoms and promoted the evolution of the cecal swhannoma until its perforation. This complication was not described before. Local recurrence has been also rarely reported in the literature. Association with neurofibroma may be hereditary in a context of neurofibromatosis or sporadic.
CONCLUSION: Colonic schwannoma may have polymorphic presentation mimicking malignant tumor in such cases. Not treated in time, it can lead to severe complications, such as tumoral perforation. Surgical resection remains the mainstay treatment. The slow evolutionary genius of schwannoma, even when incompletely resected by necessity, confirms its good prognosis.
© The Author(s) 2022.

Entities:  

Keywords:  colon; outcome; schwannoma; treatment

Year:  2022        PMID: 35774844      PMCID: PMC9237920          DOI: 10.1177/20363613221110837

Source DB:  PubMed          Journal:  Rare Tumors        ISSN: 2036-3605


Background

The Schwannoma is a tumor arising from the Schwann cells. This tumor can be found throughout the body along the peripheral nerves, but its colonic location is extremely rare (<5% of all gastrointestinal tract schwannomas). In decreasing frequency, they are located in the caecum, sigmoid, rectosigmoid, transverse colon and the descending colon. Colonic shwannomas are commonly described in elderly patient. The circumstances of diagnosis are those of an uncomplicated colonic tumor. Although considered benign, it may recur locally if incompletely resected.[1,3,4] Locoregional or liver metastasis are observed in aggressive tumors (2%). Radical surgery is, therefore, the gold standard of treatment.

Case Report

This is the case of a 23-year-old girl with a history of learning disability since childhood secondary to meningitis; who presented to a regional hospital emergency with a generalized abdominal pain that had been evolving for 2 days. At initial examination; the patient had a clinicobiological presentation of generalized peritonitis. Abdominal ultrasonography showed significant infiltration of the periappendicular fat with intraperitoneal effusion of low to medium abundance. As the patient had signs of septic shock, we decided to operate her through median laparotomy, peritonitis due to appendicular perforation was highly suspected. Peroperative exploration showed a purulent effusion of average abundance with food debris secondary to a perfoartion of a voluminous tumoral mass of the ceacum. The tumor was fixed posteriorly. It invades the adjascent structures. The palpation of the liver and the right annexe did not find secondary lesions and there were no nodules of carcinomatosis. The right mesocolon was strewn with adenomegaly, the tumor adhered posteriorly to the second duodenum. A right hemicolectomy R2 was performed with ileostomy (Figure 1). The postoperative course was marked by a state of septic shock requiring her transfer to our university hospital and 12 days stay in Intensive Care Unit.
Figure 1.

Right colectomy specimen: perforated tumor of the ceacum.

Right colectomy specimen: perforated tumor of the ceacum. Pathological examination of the surgical specimen concluded to a mesenchymal tumor of stromal origin and the immunohistochemistry allowed the diagnosis of right colon schwannoma (Figure 2).
Figure 2.

Anatomopathological examination of the specimen H.E *200: Verocay Nodule: alternation between hypercellular area and hypocellular area (Antoni A and B areas respectively).

Anatomopathological examination of the specimen H.E *200: Verocay Nodule: alternation between hypercellular area and hypocellular area (Antoni A and B areas respectively). A thoracoabdominopelvic CT scan performed 2 months later showed a 3.5 × 2.5 cm tumoral residue at right iliac fossa and no secondary site (Figure 3).
Figure 3.

CT Scan 2 months postoperatively: stability of the tumoral residue on right iliac fossa.

CT Scan 2 months postoperatively: stability of the tumoral residue on right iliac fossa. This case was discussed in multidisciplinary meeting and the decision was to make a complementary resection of the tumoral residue when restoring continuity (after 3 months from initial surgery). This complement of resection was not feasible since the tumoral residue was invading right annexe; right iliac vessels and right ureter. We had only restore the digestive continuity. The patient has been followed regularly at our outpatient clinic. Two years postoperatively CT scanning control showed a tissue mass involving the small bowel measuring 13 x 8 x 6 cm corresponding to mesenteric recurrence, with stablity of the old tumoral residue in the right iliac fossa (Figure 4).
Figure 4.

CT scanning control 2 years postoperatively: bulky mesenteric mass.

CT scanning control 2 years postoperatively: bulky mesenteric mass. Exploratory laparotomy was performed showing a voluminous mass invading the root of the mesentery and multiple parietal nodules (Figure 5). This mass was unresectable given the risk of compromising the residual small bowel’s vascularization. Surgical biopsies of the parietal nodules confirmed their neurofibrmatous nature.
Figure 5.

Exploratory laparotomy: bulky unresectable mass invading the root of the mesentery.

Exploratory laparotomy: bulky unresectable mass invading the root of the mesentery. No adjuvant treatment was indicated on multidisciplinary meeting, since the tumor was unresactable and since there is no based evidence medicine indication of raditherapy or chemotherapy. Otherwise, neurofibromatosis was suspected in our patient, but she didn’t have oncogenetic investigation since lack of major criteria justifying the realization of such relatively expensive investigations. The 4 year follow-up of the patient didn’t reveal any complications, rather then need to right nephrostomy due to ureter compression by the primary tumoral residue.

Discussion

Schwannomas were first described by Verocay in 1910.[1,3] They are neurogenic tumors of the gastrointestinal tract arising from the Schwann cells of the nerve sheath. Because of the small number of cases of schwannomas located in the digestive tract, the epidemiological pattern and the clinicopathological features of this tumor are not fully established. Schwannomas are seen in both genders equally and are mostly found after the sixth and seventh decades of life, but can appear at any age.[1,3,5] The young age of our patient is unusual. Intraperitoneal schwannomas are mostly located in the stomach. Schwannomas of the colon and rectum are uncommon and incompletely caracterized tumors.[1,4] Patients with colorectal schwannoma are usually asymptomatic, but in some cases, tenesmus, rectal bleeding, colonic obstruction and abdominal pain can be experienced.[1,3,6] The most common location is ceacum followed by sigmoid and transverse colon, descending colon, and rectum. In our literature review we didn’t find a case presenting colonic schwannoma perforation. Our patient may not complain of any symptom until the tumor perforation due to the context of the mental disability. The diagnosis of certainty is mostly obtained postoperatively through the pathhologic examination of the specimen. Preoperative diagnosis of schwannoma is difficult due to its tissue density and the tendency for ulceration. Biopsies are oftenly noncontributing. Colonoscopy, abdominal ultrasound (US), abdominal CT and abdominal magnetic resonance imaging (MRI) may aid in evaluating the contours of colorectal schwannomas and their relationship with surrounding organs, as well as tumor multiplicity or metastasis, such as the diagnostic approach in any other colorectal tumor. Immunohistochemical analysis of the tumor cells remains the most important diagnostic tool.[5,7] Many pathological criteria have been studied in relation to tumor behavior, and so far no single criterion alone allows sufficient prediction of the degree of malignancy. A mitotic activity rate of more than 5 mitoses per field at high magnification and a tumor size greater than 5 cm tend to be associated with a high risk of metastasis or recurrence.[5,8,9] Malignant profile was judged based on long-term local and distal recurrence. Colonic schwannomas are known as usually slow-growing tumors. Although they are considered as benign tumors in 98% of cases, local recurrence has been reported rarely in the literature after complete surgical resection and was considered as a clinical criterion of malignancy. Moreover, they may recur locally if excision is incomplete.[4,10] In the case of our patient, we can’t retain malignancy because the primary tumor was incompletely resected and was perforated initially. Not only that, but also our patient survived 4 years after the initial surgery with the tumoral residue and 2 years with the mesenteric recurrence. All these facts confirmed the slow evolutionary genius of schwannoma. The best therapeutic option is complete surgical removal with wide resection margins.[1,11] Lymph nodes resection is not recommended when the diagnosis is certain preoperatively, because the risk of malignant transformation is low.[11,12] For more aggressive tumors, the same surgical criteria should be used, but greater rigor in postoperative follow-up is recommended. The surgical approach depends on the size and location of the tumor and on its histopathologic pattern.[4,5] Our patient had an R2 right hemicolectomy because of the involvement of the right annexes, ureter and iliac vessels. Our conservative attitude for the residue was justified by the histological benignity of the tumor and the stability of its aspect in the different CT scanning control. Furthermore, association with neurofibroma may be hereditary in a context of neurofibromatosis or sporadic. The role of radiotherapy or chemotherapy to date remains unclear and there is no consensus for the indication of adjuvant chemoradiotherapy.[3,14,15]

Conclusion

Colonic schwannoma may have multiple presentation mimicking malignant tumor in such cases. Not treated in time, it can lead to severe complications that can compromise the vital prognosis, such as perforation and peritonitis. The mainstay treatment is complete surgical resection. The slow evolutionary genius of schwannoma, even when incompletely resected by necessity, confirms its good prognosis.
  14 in total

1.  Schwannoma of the gastrointestinal tract: a clinicopathological, immunohistochemical and ultrastructural study of 33 cases.

Authors:  Y Y Hou; Y S Tan; J F Xu; X N Wang; S H Lu; Y Ji; J Wang; X Z Zhu
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

2.  Schwannoma of the sigmoid colon.

Authors:  Tuğrul Çakır; Arif Aslaner; Müjgan Yaz; Umut rıza Gündüz
Journal:  BMJ Case Rep       Date:  2015-05-14

3.  Case report of schwannoma of the rectum--clinical and pathological contribution.

Authors:  A Maciejewski; D Lange; J Włoch
Journal:  Med Sci Monit       Date:  2000 Jul-Aug

4.  Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases.

Authors:  M Miettinen; K M Shekitka; L H Sobin
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

Review 5.  Neurofibromatosis and Schwannomatosis.

Authors:  Scott R Plotkin; Antje Wick
Journal:  Semin Neurol       Date:  2018-03-16       Impact factor: 3.420

6.  A case of benign schwannoma of the ascending colon treated with laparoscopic-assisted wedge resection.

Authors:  Se-Jin Baek; Won Hwangbo; Jin Kim; In-Sun Kim
Journal:  Int Surg       Date:  2013 Oct-Dec

7.  Combined laparoscopic-endoscopic resections of colorectal polyps: 10-year experience and follow-up.

Authors:  Dirk Wilhelm; Stefan von Delius; Lars Weber; Alexander Meining; Armin Schneider; Helmut Friess; Roland M Schmid; Eckart Frimberger; Hubertus Feussner
Journal:  Surg Endosc       Date:  2009-01-24       Impact factor: 4.584

8.  Schwannoma of the colon: A case report and review of the literature.

Authors:  Wei-Bing Wang; Wen-Bin Chen; Jian-Jiang Lin; Jia-He Xu; Jin-Hai Wang; Qin-Song Sheng
Journal:  Oncol Lett       Date:  2016-02-24       Impact factor: 2.967

Review 9.  Schwannoma of the colon and rectum: a systematic literature review.

Authors:  Ali Bohlok; Melody El Khoury; Anne Bormans; Maria Gomez Galdon; Michael Vouche; Issam El Nakadi; Vincent Donckier; Gabriel Liberale
Journal:  World J Surg Oncol       Date:  2018-07-03       Impact factor: 2.754

10.  Schwannoma of ascending colon treated by laparoscopic right hemicolectomy.

Authors:  Hun Jin Kim; Chang Hyung Kim; Sang Woo Lim; Jung Wook Huh; Young Jin Kim; Hyeong Rok Kim
Journal:  World J Surg Oncol       Date:  2012-05-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.